| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
EVP Research And Development
1 company
Stahl Neil is an EVP Research And Development at REGENERON PHARMACEUTICALS, INC.. Recent SEC Form 4 filings include 0 buys and 82 sells.
Estimated insider holdings value: $29.8M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 8, 2024 | REGN Regeneron Pharmaceuticals, Inc. | EVP Research And Development | Sell | 5,197 | $1,084.54 | $5,636,346.27 | -1.6% | -26.6% | -49.4% | |
| Feb 7, 2024 | REGN Regeneron Pharmaceuticals, Inc. | EVP Research And Development | Sell | 8,037 | $950.35 | $7,637,953.96 | -2.0% | +3.4% | -23.1% | |
| Aug 22, 2023 | REGN Regeneron Pharmaceuticals, Inc. | EVP Research And Development | Sale+OE | 11,665 | $840.98 | $9,810,082.23 | -6.6% | -4.6% | +41.0% | |
| Aug 5, 2022 | REGN Regeneron Pharmaceuticals, Inc. | EVP Research And Development | Sale+OE | 23,782 | $612.61 | $14,569,134.05 | -2.3% | +20.4% | +24.9% | |
| May 17, 2021 | REGN Regeneron Pharmaceuticals, Inc. | EVP Research And Development | Sale+OE | 17,521 | $519.46 | $9,101,459.71 | -16.2% | +20.0% | +27.5% | |
| May 11, 2020 | REGN Regeneron Pharmaceuticals, Inc. | EVP Research And Development | Sale+OE | 5,305 | $569.52 | $3,021,288.85 | -8.6% | - | - | |
| Apr 14, 2020 | REGN Regeneron Pharmaceuticals, Inc. | EVP Research And Development | Sale+OE | 5,497 | $521.07 | $2,864,306.82 | -5.2% | - | - | |
| Feb 27, 2020 | REGN Regeneron Pharmaceuticals, Inc. | EVP Research And Development | Sale+OE | 10,493 | $452.12 | $4,744,079.83 | -2.2% | - | - | |
| Feb 13, 2020 | REGN Regeneron Pharmaceuticals, Inc. | EVP Research And Development | Sale+OE | 10,278 | $400.66 | $4,117,957.89 | -13.2% | - | - | |
| Nov 26, 2019 | REGN Regeneron Pharmaceuticals, Inc. | EVP Research And Development | Sale+OE | 4,006 | $364.07 | $1,458,466.56 | -5.4% | - | - |